Flebogrif机械化学消融治疗大隐静脉功能不全的1年结果
本研究回顾性分析61例患者共105条功能不全大隐静脉接受Flebogrif机械化学消融的1年结局。术后1、6、12个月解剖成功率分别为100%、98.4%、95.4%,不良事件轻微,无感觉异常或深静脉血栓等严重并发症。修订静脉临床严重程度评分和慢性静脉功能不全生活质量问卷评分较基线显著降低。
要点
- Flebogrif机械化学消融治疗功能不全大隐静脉1年解剖成功率达95.4%。
- 不良事件轻微,无感觉异常或深静脉血栓等严重并发症。
- 可安全处理多条静脉,每次手术平均泡沫硬化剂剂量17.70±6.13 mL。
核心结论
- Flebogrif是治疗多条功能不全大隐静脉安全有效的技术。
研究设计与样本
- 回顾性分析61例患者共105条功能不全大隐静脉接受Flebogrif治疗。
主要发现
- 术后1、6、12个月解剖成功率分别为100%、98.4%、95.4%。
- 不良事件轻微,无感觉异常或深静脉血栓等严重并发症。
- 修订静脉临床严重程度评分和慢性静脉功能不全生活质量问卷评分较基线显著降低。
关键数值与推荐
- 每次手术平均泡沫硬化剂剂量为17.70±6.13 mL。
临床怎么用
- Flebogrif可用于功能不全大隐静脉的机械化学消融,支持多条静脉同期处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Flebogrif introduces a novel mechanochemical ablation technique for the treatment of incompetent saphenous veins. However, studies evaluating its efficacy as a relatively new treatment technique remain scarce. This study aimed to evaluate 1-year clinical outcomes after its application. METHODS: We conducted a retrospective analysis of 61 patients with 105 incompetent great saphenous veins who underwent treatment with Flebogrif. Primary outcomes included anatomical success rates at 1, 6, and 12 months post procedure, with secondary outcomes including adverse events, pain scores, Revised Venous Clinical Severity score, Chronic Venous Insufficiency Quality of Life Questionnaire scores, time to resumption of normal activities, and foam sclerosant dosage. RESULTS: The anatomical success rates were 100% at 1 month, 98.4% at 6 months, and 95.4% at 12 months. Adverse events were mild, with no severe complications such as paresthesia or deep vein thrombosis. Flebogrif facilitated the treatment of multiple veins without related adverse events, averaging a foam sclerosant dosage of 17.70 ± 6.13 mL per procedure. Both the Revised Venous Clinical Severity score and Chronic Venous Insufficiency Quality of Life Questionnaire scores demonstrated a significant reduction from baseline. CONCLUSIONS: Flebogrif is a safe and effective technique for the treatment of multiple incompetent saphenous veins.
引用
- Park I, Park S. One-year outcomes of mechanochemical ablation of incompetent saphenous veins using the Flebogrif device. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 41135794. doi:10.1016/j.jvsv.2025.102345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。